Výsledky vyhledávání - "Takuma Tsuzuki Wada"

Akademický článek

New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review

Autor: Mayumi Matsuda, Yu Funakubo Asanuma, Kyohei Emoto, Sakon Sakai, Nobuhito Okumura, Hiroaki Yazawa, Takashi Maruyama, Takuma Tsuzuki Wada, Kazuhiro Yokota, Yasuto Araki, Yuji Akiyama, Toshihide Mimura

Publikováno v: Immunological Medicine, Vol 47, Iss 3, Pp 205-216 (2024)

Vaccines against coronavirus disease 2019 (COVID-19) have been distributed in most countries for the prevention of onset and aggravation of COVID-19. Recently, there have been increasing numbers of reports on new-onset autoimmune and autoinflammatory

Externí odkaz: https://doaj.org/article/657e7e4c5441416d8706fc3137daed9d

Zobrazit plný text záznamu

Akademický článek

Efficacy, safety, and adherence of tocilizumab therapy in elderly patients with rheumatoid arthritis: A real-world observational study

Autor: Yoshinobu Nakao, Yu Funakubo Asanuma, Takuma Tsuzuki Wada, Mayumi Matsuda, Hiroaki Yazawa, Yoshihiro Yoshida, Akira Todoriki, Ayumi Shintani, Toshihide Mimura

Publikováno v: European Journal of Inflammation, Vol 19 (2021)

Objective: We evaluated the efficacy, safety, and drug survival rate of tocilizumab in the elderly patients with rheumatoid arthritis (RA). Methods: This study was conducted in 108 RA patients who started tocilizumab between 2008 and 2018. The patien

Externí odkaz: https://doaj.org/article/40bf5bde4d984b6b9bd4dfa2440ba935

Zobrazit plný text záznamu

Plný text ve formátu HTML

New-onset Adult-onset Still's Disease Following COVID-19 Vaccination: Three Case Reports and a Literature Review

Autor: Mayumi, Matsuda, Yu, Funakubo Asanuma, Kazuhiro, Yokota, Sakon, Sakai, Hiroaki, Yazawa, Takashi, Maruyama, Takuma, Tsuzuki Wada, Yasuto, Araki, Toshihide, Mimura

Publikováno v: Internal Medicine. 62:299-305

Since December 2020, coronavirus disease 2019 (COVID-19) vaccines have been distributed in most countries to prevent the onset and aggravation of COVID-19. There is little information regarding the long-term safety of the vaccines. We report three ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::522c3949491d42063871d3194f3d6d90
https://doi.org/10.2169/internalmedicine.0590-22

Zobrazit plný text záznamu

Evaluation of anti-severe acute respiratory syndrome coronavirus 2 antibody levels in coronavirus disease breakthrough infection during immunosuppressive therapy in a patient with connective tissue disease-related interstitial lung disease

Autor: Takuma Tsuzuki Wada, Kazuhiro Yokota, Sakon Sakai, Machika Soma, Hiroshi Kajiyama, Norihito Tarumoto, Shigefumi Maesaki, Takuya Maeda, Makoto Nagata, Toshihide Mimura

Publikováno v: Modern Rheumatology Case Reports. 7:288-292

Herein, we report the case of a 67-year-old man with severe coronavirus disease (COVID-19) pneumonia and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine breakthrough infection during immunosuppressive therapy for connective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa6d8ffbe26ad77f883fff92ece4dc2
https://doi.org/10.1093/mrcr/rxac052

Zobrazit plný text záznamu

Transition from epoprostenol to selexipag in a patient with systemic sclerosis and pulmonary hypertension during the postoperative period of colon cancer surgery: A case report

Autor: Takuma Tsuzuki Wada, Kazuhiro Yokota, Shinichiro Iida, Yuki Kanno, Nozomi Shinozuka, Kojiro Sato, Yu Funakubo Asanuma, Keiji Yamamoto, Toshihide Mimura

Publikováno v: J Scleroderma Relat Disord

Introduction: Most pulmonary vasodilators are administered orally; however, in patients with pulmonary hypertension undergoing gastrointestinal surgery, a switch to parenteral drugs is needed. Parenteral pulmonary vasodilators carry a risk of infecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a792169c112017d4bd16c604af896dc
https://doi.org/10.1177/23971983211063711

Zobrazit plný text záznamu

Encapsulating Peritoneal Sclerosis in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Systemic Sclerosis

Autor: Mayumi Matsuda, Kazuhiro Yokota, Takaya Ichimura, Sakon Sakai, Takashi Maruyama, Takuma Tsuzuki Wada, Yasuto Araki, Yu Funakubo Asanuma, Yuji Akiyama, Atsushi Sasaki, Toshihide Mimura

Publikováno v: Internal medicine (Tokyo, Japan).

We encountered a 57-year-old Japanese woman with encapsulating peritoneal sclerosis (EPS) in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis. The patient was admitted to our hospital because of ascites retention.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c17d0c70859f0ffe00f2baf9e4e6958
https://pubmed.ncbi.nlm.nih.gov/36288993

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání